Per Källblad

Per Källblad

Directeur Général chez
Beactica Therapeutics AB
Health Technology
Commercial Services
Miscellaneous

Profil

Per Källblad is the founder of Beactica Therapeutics AB, serving as Chief Executive Officer since 2014, with the company founded in 2006.
Former jobs include Principal at Aventis, Inc., Senior Scientist at Medivir AB from 2004 to 2006, Principal at Rhone-Poulenc Rorer, Inc., Principal at Biovitrum AB, Principal at Tibotec Virco NV, Founding Scientist at De Novo Pharmaceuticals Ltd. from 1999 to 2004, Principal at Concept Life Sciences Integrated Discovery & Dev Services Ltd., Principal at Cancer Research UK, and Principal at Roche Corp.
Education includes a doctorate from the University of Cambridge.

Postes actifs de Per Källblad

SociétésPosteDébut
Directeur Général 01/01/2006

Anciens postes connus de Per Källblad

SociétésPosteFin
MEDIVIR AB Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Per Källblad

Formation de Per Källblad

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

15

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Miscellaneous

Health Technology

Health Technology

Consumer Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Distribution Services

Roche Corp.

  1. Bourse
  2. Insiders
  3. Per Källblad
🔇